Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Edwards Lifesciences Corporation (EW) position

Yes: as of Q1 2026, Ken Griffin holds 519K shares of EW worth $42M (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$42M
Shares held
519K
% of portfolio
0.0%
Est. average buy price (i)
$70.86
est. since Q3 2024
Quarter-end price
$80.08

Estimated trade prices

Average price in quarters with purchases
$74.18
Average prices in quarters with sales
  • Q1 2026: $82.49 (1.7M shares sold)
  • Q4 2025: $82.07 (2.0M shares sold)
  • Q3 2025: $78.13 (8.5M shares sold)
  • Q2 2025: $74.58 (650K shares sold)
  • Q2 2024: $88.55 (2.0M shares sold)
  • Q4 2023: $69.58 (284K shares sold)
  • Q2 2023: $86.92 (987K shares sold)
  • Q2 2022: $103.52 (9K shares sold)
  • Q1 2022: $112.18 (14K shares sold)
  • Q4 2021: $116.64 (148K shares sold)
  • Q2 2021: $94.26 (671K shares sold)

EW price vs Griffin's position

Dates
$60$80$1002026Sold 8.5M shares (66.7%) · Q3 2025. Average closing price $78.13 · Price range $73.75–$81.838.5MsharessoldSold 2.0M shares (48.0%) · Q4 2025. Average closing price $82.07 · Price range $72.65–$86.942.0MsharessoldSold 1.7M shares (76.4%) · Q1 2026. Average closing price $82.49 · Price range $76.44–$87.181.7Msharessold← Earlier —8 purchases, 8 sells
Average closing price · filing quarter
$82.49
Price range · filing quarter
$76.44 – $87.18

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −1.7M −$139M −76.4% 519K May 15, 2026
Q4 2025 Reduced −2.0M −$167M −48.0% 2.2M Feb 17, 2026
Q3 2025 Reduced −8.5M −$664M −66.7% 4.2M Nov 14, 2025
Q2 2025 Reduced −650K −$49M −4.9% 12.7M Aug 14, 2025
Q1 2025 Added +4.0M +$284M +42.1% 13.4M May 15, 2025
Q4 2024 Added +7.4M +$520M +372.9% 9.4M Feb 14, 2025
Q3 2024 First covered 2.0M Nov 14, 2024
Q2 2024 Reduced −2.0M −$179M −76.4% 624K Aug 14, 2024
Q1 2024 Added +2.3M +$197M +764.8% 2.6M May 15, 2024
Q4 2023 Reduced −284K −$20M −48.2% 306K Feb 14, 2024
Q3 2023 Added +585K +$47M +10,439.7% 590K Nov 14, 2023
Q2 2023 Reduced −987K −$86M −99.4% 6K Aug 14, 2023
Q1 2023 Added +516K +$41M +108.3% 992K May 15, 2023
Q4 2022 Added +114K +$8.8M +31.5% 476K Feb 14, 2023
Q3 2022 Added +353K +$34M +4,002.7% 362K Nov 14, 2022
Q2 2022 Reduced −9K −$979K −51.7% 9K Aug 15, 2022
Q1 2022 Reduced −14K −$1.5M −42.8% 18K May 16, 2022
Q4 2021 Reduced −148K −$17M −82.2% 32K Feb 14, 2022
Q3 2021 Added +110K +$13M +156.3% 180K Nov 15, 2021
Q2 2021 Reduced −671K −$63M −90.5% 70K Aug 16, 2021
Q1 2021 First covered 741K May 21, 2021
Data through Q1 2026 · filed May 15, 2026
21 grouped rows from 21 quarters

More Griffin positions

Common questions

Does Ken Griffin own EW?

Yes. As of Q1 2026, Ken Griffin disclosed 519K shares of EW, worth $42M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy EW?

Ken Griffin held EW since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell EW?

The quarter-by-quarter table above shows each sale and reduction Ken Griffin disclosed in EW. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of EW does Ken Griffin own?

Ken Griffin disclosed 519K shares of EW as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for EW?

Ken Griffin began building the EW position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.